TABLE 2

Biodistribution of 177Lu-ABY-027 (Injected Dose, 10 μg) in BALB/C nu/nu Mice Bearing HER2-Expressing SKOV-3 Xenografts

Concentration of radioactivity (%ID/g)
Organ4 h1 d2 d3 d7 d14 d
Tumor1.1 ± 0.58 ± 117 ± 715 ± 37 ± 21.3 ± 0.2
Blood5 ± 18 ± 25.3 ± 0.43.4 ± 0.40.39 ± 0.050.020 ± 0.003
Heart1.3 ± 0.32.7 ± 0.52.4 ± 0.31.9 ± 0.20.7 ± 0.20.21 ± 0.04
Lung2.1 ± 0.44.1 ± 0.73.5 ± 0.52.4 ± 0.20.6 ± 0.10.13 ± 0.03
Liver1.0 ± 0.22.8 ± 0.83.0 ± 0.72.5 ± 0.31.2 ± 0.20.52 ± 0.03
Spleen0.6 ± 0.12.3 ± 0.52.9 ± 0.52.5 ± 0.61.9 ± 0.61.0 ± 0.6
Pancreas0.45 ± 0.061.3 ± 0.21.0 ± 0.20.8 ± 0.20.27 ± 0.050.10 ± 0.03
Stomach0.41 ± 0.051.5 ± 0.21.5 ± 0.60.9 ± 0.10.25 ± 0.040.08 ± 0.01
Kidney2.6 ± 0.44.3 ± 0.83.9 ± 0.62.98 ± 0.091.3 ± 0.20.39 ± 0.06
Muscle1.4 ± 0.41.3 ± 0.21.4 ± 0.40.9 ± 0.20.36 ± 0.080.09 ± 0.03
Bone0.7 ± 0.21.3 ± 0.21.2 ± 0.41.1 ± 0.20.5 ± 0.30.5 ± 0.2
Intestines*0.9 ± 0.31.9 ± 0.53 ± 21.3 ± 0.40.40 ± 0.070.10 ± 0.02
Carcass*58 ± 1546 ± 239 ± 232 ± 212 ± 16.1 ± 0.4
  • * Data for intestines with content and carcass are presented as %ID per whole sample.

  • Data are presented as average of %ID/g ± SD, n = 4.